13F HOLDINGS REPORT
CAXTON CORP
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0000919574-25-004762
Total Value
$9.9M
Positions
11
Other Managers
0
Confidential Omitted
Yes
Holdings (11)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | REZOLUTE INC | RZLT | 1,603,986 | $7.2M | 72.60% |
| 2 | SPDR GOLD TR | GLD | 4,952 | $1.5M | 15.32% |
| 3 | BERKSHIRE HATHAWAY INC DEL | BRK-A | 632 | $307,040 | 3.12% |
| 4 | ENLIVEN THERAPEUTICS INC | ELVN | 13,097 | $262,736 | 2.67% |
| 5 | MIND MEDICINE MINDMED INC | 60255C885 | 34,073 | $221,134 | 2.24% |
| 6 | COMPASS THERAPEUTICS INC | CMPX | 43,465 | $113,010 | 1.15% |
| 7 | BICARA THERAPEUTICS INC | BCAX | 10,941 | $101,643 | 1.03% |
| 8 | KYVERNA THERAPEUTICS INC | KYTX | 22,981 | $70,552 | 0.72% |
| 9 | LEXEO THERAPEUTICS INC | LXEO | 17,332 | $69,674 | 0.71% |
| 10 | INHIBIKASE THERAPEUTICS INC | IKT | 16,393 | $31,966 | 0.32% |
| 11 | CONTEXT THERAPEUTICS INC | CNTX | 18,403 | $12,058 | 0.12% |